Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
IDCases ; 31: e01713, 2023.
Article in English | MEDLINE | ID: mdl-36852408

ABSTRACT

Syphilis cases in childhood are usually associated with congenital transmission. Acquired transmission is uncommon, and primarily related to sexual abuse or close contact/nursing with infected family members. We here describe a case of syphilis in a 14-month-old girl resulting from intrafamilial infection, with a subsequent transmission to her mother.

2.
Pediatr Blood Cancer ; 69(3): e29421, 2022 03.
Article in English | MEDLINE | ID: mdl-34842332

ABSTRACT

BACKGROUND: Ovarian mature teratoma (OMT) is a common ovarian tumor found in the pediatric population. In 10%-20% of cases, OMT occurs as multiple synchronous or metachronous lesions on ipsi- or contralateral ovaries. Ovarian-sparing surgery (OSS) is recommended to preserve fertility, but total oophorectomy (TO) is still performed. DESIGN: This study reviews the clinical data of patients with OMT, and analyzes risk factors for second events. A national retrospective review of girls under 18 years of age with OMTs was performed. Data on clinical features, imaging, laboratory studies, surgical reports, second events and their management were retrieved. RESULTS: Overall, 350 children were included. Eighteen patients (5%) presented with a synchronous bilateral form at diagnosis. Surgery was performed by laparotomy (85%) and laparoscopy (15%). OSS and TO were performed in 59% and 41% of cases, respectively. Perioperative tumor rupture occurred in 23 cases, independently of the surgical approach. Twenty-nine second events occurred (8.3%) in a median time of 30.5 months from diagnosis (ipsilateral: eight cases including one malignant tumor; contralateral: 18 cases; both ovaries: three cases). A large palpable mass, bilateral forms, at diagnosis and perioperative rupture had a statistical impact on the risk of second event, whereas the type of surgery or approach did not. CONCLUSION: This study is a plea in favor of OSS as the first-choice treatment of OMT when possible. Close follow-up during the first 5 years is mandatory considering the risk of 8.3% of second events, especially in cases with risk factors.


Subject(s)
Ovarian Neoplasms , Teratoma , Adolescent , Child , Female , Humans , Ovarian Neoplasms/pathology , Ovariectomy , Retrospective Studies , Teratoma/pathology
3.
Genes Chromosomes Cancer ; 59(2): 111-118, 2020 02.
Article in English | MEDLINE | ID: mdl-31433521

ABSTRACT

Interpretation of missense variants remains a major challenge for genetic diagnosis, even in well-known genes such as the DNA-mismatch repair (MMR) genes involved in Lynch syndrome. We report the characterization of a variant in MSH2: c.1022T>C, which was identified in 20 apparently unrelated families living in the North of France. A total of 150 patients from 20 families were included in this study. Family segregation studies, tumor analyses and functional analyses at both the RNA and protein levels were performed. Founder effect was evaluated by haplotype analysis.We show that MSH2 c.1022T>C is a missense variant (p.Leu341Pro) that affects protein stability. This variant is frequent in the North of France (7.7% of pathogenic variations identified in MMR genes), and is located on an ancestral haplotype. It is associated with a high risk of a broad tumor spectrum including brain and cutaneous cancers. The MSH2 c.1022T>C variant is a pathogenic founder variation associated with a high risk of cancer. These findings have important implications for genetic counseling and management of variant carriers.


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , MutS Homolog 2 Protein/genetics , Adult , Aged , Colorectal Neoplasms, Hereditary Nonpolyposis/epidemiology , DNA Mismatch Repair , Exons , Female , Founder Effect , France/epidemiology , Genetic Predisposition to Disease , Germ-Line Mutation , Haplotypes , Humans , Male , Microsatellite Instability , Middle Aged , MutS Homolog 2 Protein/metabolism , Mutation, Missense , Pedigree , Polymorphism, Single Nucleotide
4.
Anaerobe ; 59: 32-34, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31103530

ABSTRACT

Clostridium ventriculi (formerly Sarcina ventriculi) is a Gram-positive, obligate anaerobic coccus. Human infections due to this bacterium have rarely been reported, its involvement in the development of gastric ulcers and perforation has been suggested. We present a case of bacteremia due to C. ventriculi following acute colonic pseudo-obstruction.


Subject(s)
Bacteremia/diagnosis , Bacteremia/pathology , Clostridium Infections/diagnosis , Clostridium Infections/pathology , Clostridium/isolation & purification , Colonic Pseudo-Obstruction/complications , Aged , Bacteremia/microbiology , Clostridium Infections/microbiology , Humans , Male
5.
Future Microbiol ; 13: 659-669, 2018 05.
Article in English | MEDLINE | ID: mdl-29790796

ABSTRACT

AIM: To explore Aspergillus interactions with platelets in the blood, especially during clot formation. MATERIALS & METHODS: Aspergillus fumigatus resting or swollen conidia, germlings or hyphae were inoculated into blood sampled into tubes with or without anticoagulant. Interactions were explored using microscopy, and chemokine levels were determined. RESULTS: Anatomopathological examination of the clot revealed conidia and germlings colocalization with platelet aggregates, and neutrophil recruitment around aggregates. Transmission electron microscopy showed conidia and hyphae surrounded by neutrophils. Increased CCL5 and CXCL4 when conidia or germlings but not hyphae were added suggested they could be involved in neutrophil recruitment around aggregates. CONCLUSION: These data suggest platelets could trigger coagulopathy and activate neutrophils during aspergillosis. They open up new perspectives for aspergillosis management.


Subject(s)
Aspergillus fumigatus/immunology , Blood Coagulation , Blood Platelets/metabolism , Neutrophils/immunology , Chemokines/analysis , Healthy Volunteers , Humans , Hyphae/immunology , Microscopy , Microscopy, Electron, Transmission , Spores, Fungal/immunology
6.
Int J Cancer ; 138(6): 1472-81, 2016 Mar 15.
Article in English | MEDLINE | ID: mdl-26476272

ABSTRACT

The serrated neoplasia pathway accounts for 20-30% of colorectal cancers (CRC), which are characterized by extensive methylation (CpG island methylation phenotype, CIMP), frequent BRAF mutation and high microsatellite instability (MSI). We recently identified MUC5AC mucin gene hypomethylation as a specific marker of MSI CRC. The early identification of preneoplastic lesions among serrated polyps is currently challenging. Here, we performed a detailed pathological and molecular analysis of a large series of colorectal serrated polyps and evaluated the usefulness of mucin genes MUC2 and MUC5AC to differentiate serrated polyps and to identify lesions with malignant potential. A series of 330 colorectal polyps including 218 serrated polyps [42 goblet cell-rich hyperplastic polyps (GCHP), 68 microvesicular hyperplastic polyps (MVHP), 100 sessile serrated adenoma (SSA) and eight traditional serrated adenoma (TSA)] and 112 conventional adenomas was analyzed for BRAF/KRAS mutations, MSI, CIMP, MLH1 and MGMT methylation, and MUC2 and MUC5AC expression and methylation. We show that MUC5AC hypomethylation is an early event in the serrated neoplasia pathway, and specifically detects MVHP and SSA, arguing for a filiation between MVHP, SSA and CIMP-H/MSI CRC, whereas GCHP and TSA arise from a distinct pathway. Moreover, MUC5AC hypomethylation specifically identified serrated lesions with BRAF mutation, CIMP-H or MSI, suggesting that it may be useful to identify serrated neoplasia pathway-related precursor lesions. Our data suggest that MVHP should be recognized among HP and require particular attention.


Subject(s)
Biomarkers, Tumor , Colonic Polyps/genetics , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , DNA Methylation , Mucin 5AC/genetics , Adult , Aged , Aged, 80 and over , Cell Transformation, Neoplastic/genetics , Colonic Polyps/pathology , Colorectal Neoplasms/diagnosis , Female , Gene Expression , Humans , Male , Microsatellite Instability , Middle Aged , Mutation , Prognosis , Proto-Oncogene Proteins B-raf/genetics , ras Proteins/genetics
7.
Emerg Infect Dis ; 21(1): 91-4, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25528951

ABSTRACT

Despite increasing reports that Blastocystis infection is associated with digestive symptoms, its pathogenicity remains controversial. We report appendicular peritonitis in a 9-year-old girl returning to France from Morocco. Only Blastocystis parasites were detected in stools, appendix, peritoneal liquid, and recto-uterine pouch. Simultaneous gastroenteritis in 26 members of the child's family suggested an outbreak.


Subject(s)
Appendix/parasitology , Blastocystis Infections/diagnosis , Peritonitis/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Blastocystis/isolation & purification , Blastocystis Infections/epidemiology , Child , Child, Preschool , Disease Outbreaks , Feces/parasitology , Female , Humans , Infant , Male , Middle Aged , Morocco , Peritonitis/parasitology , Young Adult
8.
Bull Cancer ; 101(9): 813-22, 2014 Sep.
Article in French | MEDLINE | ID: mdl-25036236

ABSTRACT

Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant disease due to mutations in the tumor suppressor gene STK11. PJS is characterized by periorificial hyperpigmented macules (lentiginosis) and hamartomatous polyposis. Polyps can be located anywhere in the gastrointestinal tract, but are preferably observed in the small bowel (70-90%), the colon (50%) and the stomach (25%). They tend to be cancerous in a particular sequence hamartoma-dysplasia-cancer. The diagnosis is often made in the first or second decade following the appearance of lentigines or upon the occurrence of complications due to polyps (obstruction, intussusception, occult bleeding responsible for anemia). Furthermore PJS is associated with a significant increase in cancer risk (relative risk of 89% over the life according to the most recent series). Digestive cancers are the more frequent with cumulative incidences of 55% for gastro-intestinal cancer (39% for colorectal cancer, 13% for small bowel cancer and between 11 and 36% for pancreatic cancer, respectively). There is also an increased risk of non digestive cancers. In particular the risk of breast cancer is similar to that of patients carrying deleterious BRCA1 or BRCA2 mutations (cumulative incidence of 45%). Gynecological and gonadal tumors are frequent as well and can be more (adenoma malignum) or less aggressive (ovarian sex cord tumors with annular tubules and testicular tumors with calcified Sertoli cells). Finally the frequency of lung cancer is moderately increased. Recommendations for screening and management based on retrospective series in the literature have led to various strategies. The aim of this paper is to summarize the clinical and molecular diagnostic criteria of PJS as well as recommendations on screening strategies, management and monitoring.


Subject(s)
Breast Neoplasms/genetics , Digestive System Neoplasms/genetics , Genetic Predisposition to Disease , Genital Neoplasms, Female/genetics , Peutz-Jeghers Syndrome/genetics , Protein Serine-Threonine Kinases/genetics , AMP-Activated Protein Kinase Kinases , Female , Humans , Intestinal Polyps/diagnosis , Intestinal Polyps/genetics , Male , Peutz-Jeghers Syndrome/diagnosis , Pregnancy , Prenatal Diagnosis
11.
Hum Pathol ; 43(12): 2255-65, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22809729

ABSTRACT

Adenoid basal hyperplasia is an underrecognized cervical lesion, resembling adenoid basal carcinoma, except the absence of deep invasion into the stroma. We report a series of 10 cases, all extending less than 1 mm from the basement membrane. Our results support the hypothesis that adenoid basal hyperplasia arises from reserve cells of the cervix. Lesions were found close to the squamocolumnar junction, in continuity with the nearby subcolumnar reserve cells. They shared the same morphology and immunoprofile using a panel of 4 antibodies (keratin 5/6, keratin 14, keratin 7 and p63) designed to differentiate reserve cells from mature squamous cells and endocervical columnar cells. We detected no human papillomavirus infection by in situ hybridization targeting high-risk human papillomavirus, which was concordant with the absence of immunohistochemical p16 expression. We demonstrated human papillomavirus infection in 4 (80%) of 5 adenoid basal carcinoma, which is in the same range as previous studies (88%). Thus, adenoid basal hyperplasia should be distinguished from adenoid basal carcinoma because they imply different risk of human papillomavirus infection and of subsequent association with high-grade invasive carcinoma. In our series, the most reliable morphological parameters to differentiate adenoid basal hyperplasia from adenoid basal carcinoma were the depth of the lesion and the size of the lesion nests. Furthermore, squamous differentiation was rare in adenoid basal hyperplasia and constant in adenoid basal carcinoma. Finally, any mitotic activity and/or an increase of Ki67 labeling index should raise the hypothesis of adenoid basal carcinoma.


Subject(s)
Carcinoma, Adenoid Cystic/pathology , Carcinoma, Basal Cell/pathology , Cervix Uteri/pathology , Uterine Cervical Neoplasms/pathology , Adult , Aged , Carcinoma, Adenoid Cystic/metabolism , Carcinoma, Basal Cell/metabolism , Cervix Uteri/metabolism , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Humans , Hyperplasia/pathology , Keratins/metabolism , Middle Aged , Uterine Cervical Neoplasms/metabolism
13.
Dig Dis Sci ; 57(5): 1271-80, 2012 May.
Article in English | MEDLINE | ID: mdl-22198706

ABSTRACT

AIMS: To evaluate the utility of laser microdissection in the comparison of phenotypes and genetic alterations between colon cancer and corresponding liver metastasis in the context of intratumoral heterogeneity. METHODS: Immunohistochemistry was performed on a series of 11 patients surgically treated for colon adenocarcinoma with liver metastases, using antibodies directed against six mucins. Immunohistochemistry was completed by laser microdissection of tumor zones with particular phenotype, luminal zone and invasion front of colon tumors. Microdissected samples were compared on the basis of microsatellite instability and alterations of CTNNB1, KRAS, and TP53. RESULTS: Our study demonstrated varying mucin expression within tumors, suggesting the existence of phenotypic intratumoral heterogeneity. A common immunohistochemical profile was observed in individual tumors between tumoral subpopulations and corresponding metastases. Nevertheless, the phenotypic characteristics were distinct from one patient to another. Laser microdissection underlined that phenotypic heterogeneity could rely on genotypic heterogeneity, and that some genetic alterations were common to microdissected samples from primary colon tumors and liver metastases. CONCLUSION: We illustrated intratumoral heterogeneity of colon cancer using laser microdissection, in combination with immunohistochemical and genotypic tools. This intratumoral heterogeneity could represent a major issue in the search of prognostic biomarkers.


Subject(s)
Adenocarcinoma/secondary , Colonic Neoplasms , Laser Capture Microdissection , Liver Neoplasms , Proto-Oncogene Proteins/genetics , beta Catenin/genetics , ras Proteins/genetics , Aged , Colon/pathology , Colonic Neoplasms/genetics , Colonic Neoplasms/pathology , Female , Genetic Heterogeneity , Genotyping Techniques/methods , Humans , Immunohistochemistry/methods , Laser Capture Microdissection/methods , Laser Capture Microdissection/statistics & numerical data , Liver Neoplasms/genetics , Liver Neoplasms/secondary , Male , Microsatellite Instability , Microsatellite Repeats , Middle Aged , Phenotype , Prognosis , Proto-Oncogene Proteins p21(ras) , Tumor Suppressor Protein p53/genetics
14.
J Med Case Rep ; 5: 280, 2011 Jul 03.
Article in English | MEDLINE | ID: mdl-21722406

ABSTRACT

INTRODUCTION: Hemophagocytic lymphohistiocytosis induced by viral diseases is a well recognized entity. Severe forms of H5N1 influenza are known to be associated with symptoms very similar to a reactive hemophagocytic syndrome. We report a case of fulminant lymphohistiocytosis associated with the pandemic A (H1N1) variant. CASE PRESENTATION: A 42-year-old Caucasian woman developed a syndrome of fatal hemophagocytic lymphohistiocytosis shortly after H1N1 influenza. Initial symptoms of the viral disease were unusual, with acute abdominal involvement. Our patient's course was complicated by diffuse skin rash and ileal ischemia. Our patient died of refractory shock and multi-organ failure. Skin, ileum and colon histology was consistent with an acute apoptosis combined with an increased cellular regeneration. CONCLUSIONS: Influenza may be complicated by severe forms of hemophagocytic lymphohistiocytosis. To ensure early recognition and treatment, physicians should be aware of the possible induction of the syndrome by the novel H1N1 variant. The rapid occurrence of a multi-organ involvement with evocative biological features of macrophage activation should alert clinicians.

15.
World J Gastroenterol ; 14(7): 1053-9, 2008 Feb 21.
Article in English | MEDLINE | ID: mdl-18286687

ABSTRACT

AIM: To investigate the polymorphic simple sequence repeat in intron 1 of the epidermal growth factor receptor gene (EGFR) (CA-SSR I), which is known to affect the efficiency of gene transcription as a putative target of the mismatch repair (MMR) machinery in colorectal tumors. METHODS: The CA-SSR I genotype was analyzed in a total of 86 primary colorectal tumors, selected upon their microsatellite instability (MSI) status [42 with high frequency MSI (MSI-H) and 44 microsatellite stable (MSS)] and their respective normal tissue. The effect of the CA-SSR I genotype on the expression of the EGFR gene was evaluated in 18 specimens using quantitative real-time reverse transcription PCR and immunohistochemistry. RESULTS: Mutations in CA-SSR I were detected in 86% (36 of 42) of MSI-H colorectal tumors and 0% (0 of 44) of MSS tumors, indicating the EGFR gene as a novel putative specific target of the defective MMR system (P < 0.001). Impaired expression of EGFR was detected in most of the colorectal tumors analyzed [6/12 (50%) at the mRNA level and 15/18 (83%) at the peptide level]. However, no association was apparent between EGFR expression and CA-SSR I status in tumors or normal tissues. CONCLUSION: Our results suggest that CA-SSR I sequence does not contribute to the regulation of EGFR transcription in colon, and should thus not be considered as a promising predictive marker for response to EGFR inhibitors in patients with colorectal cancer.


Subject(s)
Colorectal Neoplasms/genetics , Dinucleotide Repeats , Genes, erbB-1 , Minisatellite Repeats , Mutation , Colorectal Neoplasms/metabolism , DNA Mismatch Repair , Genotype , Humans , Immunohistochemistry , Introns , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Neoplasm/genetics , RNA, Neoplasm/metabolism
17.
Anticancer Drugs ; 17(7): 855-7, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16926635

ABSTRACT

In patients with metastatic colorectal cancer, the use of cetuximab currently requires a documented tumoral epidermal growth factor receptor positivity. Responses to cetuximab, however, have been described in patients with epidermal growth factor receptor-negative tumors. We have used cetuximab in all eligible patients with metastatic colorectal cancer, whether their tumor expressed epidermal growth factor receptor or not. We assessed the cetuximab efficacy with regard to tumoral epidermal growth factor receptor expression. Twenty patients with metastatic colorectal cancer were treated off study with cetuximab and irinotecan after failure of oxaliplatin- and irinotecan-based regimens. Tumors were analyzed in all patients for epidermal growth factor receptor expression by immunohistochemistry. Tumors were positive for epidermal growth factor receptor in 12 cases and negative in eight cases. An objective response to cetuximab-based therapy was obtained in four patients (20%). Tumors of these four patients were negative for epidermal growth factor receptor expression. These results provide further evidence for the lack of usefulness of epidermal growth factor receptor detection by immunohistochemistry for cetuximab therapy in patients with metastatic colorectal cancer.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/therapeutic use , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/metabolism , ErbB Receptors/biosynthesis , Adult , Aged , Antibodies, Monoclonal, Humanized , Antineoplastic Agents, Phytogenic/therapeutic use , Biomarkers , Camptothecin/analogs & derivatives , Camptothecin/therapeutic use , Cetuximab , Female , Humans , Immunohistochemistry , Irinotecan , Male , Middle Aged , Neoplasm Metastasis , Survival
19.
World J Gastroenterol ; 12(21): 3324-31, 2006 Jun 07.
Article in English | MEDLINE | ID: mdl-16733847

ABSTRACT

AIM: To investigate the expression of the four secreted gel-forming mucins (MUC2, MUC5AC, MUC5B and MUC6) in a series of gastric carcinomas, classified according Lauren's, Mulligan's, WHO and Goseki's classifications, with special attention to all the different components (major and minor) present in tumors and to follow up clinical data. METHODS: Expression of MUC2, MUC5AC, MUC5B and MUC6 was investigated using immunohistochemistry and in situ hybridization. RESULTS: Expression of secreted gel-forming mucins in gastric carcinoma was particularly complex, each mucin being not restricted to any histopathological type even considering all components (major and minor) present in a given tumor. There was a worst survival in patients with a higher content of mucus (Goseki II or IV) and high positive MUC2 expression. CONCLUSION: Complexity of mucin gene expression patterns in gastric cancer may reflect a precise state of differentiation at the cell level not recognized in used morphologic classification systems. High expression of MUC2 was nevertheless associated with mucinous subtype of the WHO classification and with group II of Goseki's classification identified by the major component of a particular tumor. The quantity and quality of mucus were related to survival.


Subject(s)
Adenocarcinoma, Mucinous/chemistry , Mucins/genetics , Stomach Neoplasms/chemistry , Adenocarcinoma, Mucinous/genetics , Adenocarcinoma, Mucinous/pathology , Adult , Aged , Aged, 80 and over , Female , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Male , Middle Aged , Mucin-2 , Mucins/analysis , Neoplasm Staging , Prognosis , Retrospective Studies , Stomach Neoplasms/genetics , Stomach Neoplasms/pathology , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...